StoneX Group’s Propanc Biopharma PPCB Stock Holding History

StoneX Group’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.54K	Buy	+1,109	New	+$12.9K	﹤0.01%	1893

StoneX Group's PPCB Position: Q3 2026 in Review

StoneX Group opened a new position in Propanc Biopharma (PPCB) in Q3 2026: 1,109 shares worth $5.54K. The stake represents ﹤0.01% of the portfolio and ranks #1893 among its holdings.

1 fund tracked by Wall St. Rank holds PPCB as of Q3 2026.

StoneX Group held 1,109 shares of Propanc Biopharma worth $5.54K as of Q3 2026.
Propanc Biopharma was a new StoneX Group position in Q3 2026.
Propanc Biopharma made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1893 holding.
1 fund tracked by Wall St. Rank held Propanc Biopharma as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.